NasdaqGS:NVAXBiotechs
Novavax (NVAX): Assessing Valuation After Japan Vaccine Approval and Takeda Milestone Payment
Novavax (NVAX) has been in the spotlight after its COVID-19 vaccine, Nuvaxovid, secured regulatory approval in Japan. This approval unlocked a milestone payment from partner Takeda and set up Novavax to receive royalties from upcoming Nuvaxovid sales during the vaccination season. What makes this event stand out is the improved collaboration agreement between the two companies, aiming to boost Novavax's presence and commercial opportunity in Japan. Japan is an important market for any global...